| Human SEZ6L2 Protein (LTP10287) |
| LTP10287 |
| 100ug |
|
$406 In stock |
| Seizure-related 6 homolog (mouse)-like 2 (SEZ6L2) was shown to be involved in transcription of a type 1 transmembrane protein for regulating cell fate. SEZ6L2 was significantly up-regulated in tumour tissues of patients with CRC compared with adjacent normal tissues. Up-regulation of SEZ6L2 was correlated with a poor prognosis in patients with CRC. Furthermore, SEZ6L2 expression was inversely correlated with the expression of cytochrome C in malignant tissues in patients with CRC. |
| Recombinant Human SEZ6L2 Protein is expressed from Expi293 with His tag at the C-terminal. It contains Leu28-Asn844. |
| SEZ6L2 |
| Human |
| Q6UXD5-1 |
| Leu28-Asn844 |
| The protein has a predicted MW of 88.5 kDa. Due to glycosylation, the protein migrates to 120-140 kDa based on the Tris-Bis PAGE result. |
| 0 |
| C-His |
| Expi293 |
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
| Less than 1EU per ug by the LAL method. |
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipped at ambient temperature. |
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| ![Human SEZ6L2 Protein (LTP10287)](/peptide-product/images/protein-products/LTP10287/20210924103603.png) |